Monsanto and EPA Seek to Keep Talks About Glyphosate Cancer Review a Secret
By Carey Gillam
Monsanto and officials within the U.S. Environmental Protection Agency (EPA) are fighting legal efforts aimed at exploring Monsanto's level of influence over regulatory assessments of the key chemical in the company's Roundup herbicide, new federal court filings show.
The revelations are contained in a series of filings made within the last few days in the U.S. District Court for the Northern District of California as part of litigation brought by more than 50 people who are suing Monsanto. The plaintiffs claim they or their loved ones developed non-Hodgkin lymphoma after exposure to Roundup herbicide, and that Monsanto has spent decades covering up the chemical's cancer risks.
Monsanto, California Battle Over Listing Glyphosate as a Carcinogen https://t.co/qn0xnO7Hw8— Mark Hyman, M.D. (@Mark Hyman, M.D.)1484758926.0
Lawyers for the plaintiffs want the court to lift a seal on documents that detail Monsanto's interactions and discussions with former top EPA brass Jess Rowland regarding the EPA's safety assessment of glyphosate, the active ingredient in Roundup. Monsanto turned the documents over in discovery but marked the documents "confidential," a designation plaintiffs' attorneys say is improper. They also want to depose Rowland. But Monsanto and the EPA are fighting both requests, the filings show.
The EPA has spent the last few years assessing the health and environmental safety aspects of glyphosate as global controversy over the chemical has mounted. The World Health Organization's International Agency for Research on Cancer (IARC) declared in March 2015 that glyphosate is a probable human carcinogen, with a positive association found between glyphosate and non-Hodgkin lymphoma. Monsanto has been fighting to refute that classification because of financial and legal liability ramifications.
Rowland has been key in Monsanto's efforts to rebut the IARC finding because until last year he was a deputy division director within the health effects division of the EPA's Office of Pesticide Programs, managing the work of scientists who assessed human health effects of exposures to pesticides like glyphosate. And, importantly, he chaired the EPA's Cancer Assessment Review committee (CARC) that issued an internal report in October 2015 contracting IARC's findings. That 87-page report, signed by Rowland, determined that glyphosate was "not likely to be carcinogenic."
The report was a godsend to Monsanto because it has helped bolster the company's defense against the Roundup liability lawsuits, and helped shore up market support for a product that brings in billions of dollars in revenues to the company annually. The EPA's stamp of approval for the safety of glyphosate has also been key to the success of Monsanto's genetically engineered, glyphosate-tolerant crops, which have been popular with farmers.
But the handling of the CARC report raised questions last year when it was "inadvertently" posted to a public EPA website on April 29, 2016, and kept on the site three days, before being pulled down. The agency said the report was not final and that it should not have been posted, but Monsanto touted the report as a public affirmation of its safety claims for glyphosate. The company also cited the report at a May court hearing in the Roundup litigation as a counter point to the IARC cancer classification. Shortly after the CARC report was removed from the EPA website, Rowland left his 26-year career at the EPA.
Plaintiffs' attorneys have asked to depose Rowland to learn about that situation and other dealings with Monsanto. But, along with Monsanto's objection to a release of the documents that relate to its conversations with Rowland, the EPA has specifically refused the deposition request, saying it would "not clearly be in the interests of EPA" to allow attorneys to question Rowland about the cancer review and interactions with Monsanto.
Monsanto has so far turned over roughly six million pages of documents through the court-ordered discovery process, but has designated roughly 85 percent of the information as "confidential," meaning plaintiffs' attorneys must black out information from those documents in any court filings that could be accessed by reporters or other members of the public. That designation is improper for many of the documents, especially ones dealing with the company's interactions with, and influence attempts over, EPA officials, plaintiffs' lawyers argue.
The lawyers said that the documents obtained through discovery show that "Monsanto has been confident all along that EPA would continue to support glyphosate, whatever happened and no matter who held otherwise." According to the court filings by plaintiffs' attorneys, the documents show "it is clear that Monsanto enjoyed considerable influence within the EPA's OPP, and was close with Mr. Rowland ... The documentary evidence strongly suggests that Mr. Rowland's primary goal was to serve the interests of Monsanto."
The EPA is a taxpayer-funded, public agency and its dealings with Monsanto should be subject to public scrutiny, particularly given the widespread use of glyphosate herbicide products and the current ongoing international debate over the safety of the chemical, the lawyers claim.
Breaking: EPA Panel Divided on Whether Glyphosate Causes Cancer https://t.co/4WtRfwRWpd Here's why it matters https://t.co/kX8IfqWYtX— Food Democracy Now! (@Food Democracy Now!)1482529711.0
"The health and safety of millions of U.S. citizens is at stake," states the Jan. 16 plaintiffs' filing. "Decisions affecting the public health should not be based on secret conversations between Monsanto and EPA officials. If Monsanto wants to advocate on behalf of glyphosate to EPA employees, they should have to do it publicly, so that concerned citizens have equal opportunity to advocate for their health and the health of their families. This issue is too important to allow Monsanto to improperly influence the EPA, and then hide such communication behind an improper 'confidential' designation."
Monsanto is adamant that its documents not be made public, saying releasing them would be "premature and improper." Allowing public dissemination "of a few select internal corporate documents taken out of context … would be prejudicial to Monsanto and could cause reputational harm," the company's attorneys wrote in their response.
The plaintiffs' attorneys say at least four specific documents they have obtained are clearly in the public interest and "illuminate that one of Monsanto's chief business strategies is its secret and untoward influence on EPA." The documents include both internal memos and email chains, according to descriptions of the documents.
"Since Monsanto's communications with the EPA remain secret, these known lobbying efforts are only the tip of the iceberg of Monsanto's collusion with the EPA. Monsanto's bad acts in violating U.S. regulations through secret communications with the EPA should not by rewarded by allowing them to keep these communications secret by merely stamping them 'confidential,'" the plaintiffs' attorney state in the filings. "These documents summarize communications with EPA which are not elsewhere memorialized; they are not trade secrets and the public has a compelling interest in disclosure."
Monsanto argues otherwise, saying the four documents at issue "contain sensitive, non-public commercial information, relate to a motion seeking to obtain discovery from a non-party, and bear only a tangential, at best, connection to the questions at issue in this litigation; hence, any public interest 'is minimal.'"
U.S. District Jude Vince Chhabria, who is overseeing the multi-district Roundup litigation, could rule on these matters any day.
Environmental officials and members of the U.S. Coast Guard are racing to clean up a mysterious oil spill that has spread to 11 miles of Delaware coastline.
- Trans Mountain Pipeline Spills up to 50,000 Gallons of Oil on ... ›
- Citgo Must Pay $143M for a Delaware River Oil Spill, Supreme ... ›
EcoWatch Daily Newsletter
By Dr. Kate Raynes-Goldie
Of all the plastic we've ever produced, only 9% has been recycled. So what happened to all that plastic you've put in the recycling bin over the years?
Triangle of Mistruths<p>The myth created around plastic recycling has been one of simplicity. We look for the familiar triangle arrows, then pop the waste in the recycling bin so it can be reused.</p><p>But the true purpose of those triangles has been misunderstood by the general public ever since their invention in the 1980s.</p><p>These triangles were actually created by the plastics industry and, according to a report provided to them in July 1993, <a href="https://www.npr.org/transcripts/912150085" target="_blank">were creating "unrealistic expectations"</a> about what could be recycled. But they decided to keep using the codes.</p><p>Which is why many people still believe that these triangular symbols (also known as a <a href="https://sustainablepackaging.org/101-resin-identification-codes/" target="_blank" rel="noopener noreferrer">resin identifier code</a> or RIC) means something is recyclable.</p><p>But according to the American Society for Testing and Materials International (ASTM) – which controls the RIC system – the numbered triangles "<a href="https://www.astm.org/Standards/D7611.htm" target="_blank" rel="noopener noreferrer">are not recycle codes</a>." In fact, they weren't created for the general public at all. They were made for the post-consumer plastic industry.</p><p>In other words, the symbols make it easier to sort the different types of plastics, some of which cannot be recycled – <a href="https://www.ecobin.com.au/understand-recycling-codes/" target="_blank" rel="noopener noreferrer">depending on the recycling facility</a>.</p><p>"Unfortunately, just placing your plastic into the recycling bin doesn't mean it will get recycled," says Lara Camilla Pinho. She is an architect and lecturer at the UWA School of Design who is researching novel uses of plastic waste.</p><p>"The recycling system is complicated and often dictated by market demand. Not all plastic is recyclable. We cannot recycle plastic bags or straws for example."</p>
Behind the Scenes<p>So, what makes recycling plastics so difficult?</p><p>"Essentially, there are two types of plastics – thermoplastics and thermosets. While thermoplastics can be re-melted and re-molded, thermosets contain cross-linked polymers that cannot be separated meaning they cannot be recycled," says Lara.</p><p>"Even thermoplastics have a limit to the amount of times we can recycle them, as each time they are recycled they downgrade in quality."</p><p>Even when plastics are recyclable, it is <a href="https://www.theguardian.com/environment/2019/oct/13/war-on-plastic-waste-faces-setback-as-cost-of-recycled-material-soars" target="_blank">often more costly</a> than simply making new plastics.</p>
Sugar, Seaweed and Mushrooms<p>If the conventional recycling system isn't working, what else can we do with all the plastic we've created?</p><p>Lara is looking for ways to add value to recycled plastics such as using it in the design and development of architectural products. She hopes to use these architectural products to help underserved communities that are disproportionately affected by plastic waste.</p><p>In addition to recycling, we also need to find ways to reduce our use of virgin petroleum-based plastics.</p><p>Bioplastic is one such product that has been getting a lot of hype over the last few years. And although they're better than petroleum-based plastics, bioplastics also come with their own <a href="https://phys.org/news/2017-12-truth-bioplastics.html" target="_blank">set of challenges</a>.</p><p>"There are already a lot of bio-based alternatives to plastic, such as bagasse – a byproduct of sugar cane processing," says Lara.</p><p><a href="https://blogs.scientificamerican.com/observations/the-mycelium-revolution-is-upon-us/" target="_blank" rel="noopener noreferrer">Mycelium</a>, a type of fungi we most often associate with mushrooms, are also providing an interesting plastic alternative.</p><p>"In the field of architecture, mycelium is starting to be used as an alternative to plastic insulation, but also as compostable packaging and bricks," says Lara.</p><p>"The bricks take around five days to make and are strong, durable, water resistant and compostable at the end of their use."</p><p><a href="https://www.arup.com/news-and-events/hyfi-reinvents-the-brick" target="_blank" rel="noopener noreferrer">Hy-Fi Tower</a>, created by <a href="http://www.thelivingnewyork.com/living_about.html" target="_blank" rel="noopener noreferrer">The Living</a>, is an example of a building made from these bricks.</p><p>And finally, there's seaweed.</p><p>"[Seaweed is] cheap and can reproduce itself quickly without fertilizers. In architecture, there is use for seaweed as an alternative to plastic insulation but also as cladding," says Lara.</p>
More Money, More Problems<p>While all these alternatives are great, the main cause of our plastic dilemma is not scientific or technological, but economic.</p><p>As long as it remains <a href="https://engineering.mit.edu/engage/ask-an-engineer/why-is-it-cheaper-to-make-new-plastic-bottles-than-to-recycle-old-ones/" target="_blank">cheaper to create new plastics</a> from fossil fuels rather than from bioplastics or from recycling, we're going to be stuck with plastic garbage islands floating in our oceans.</p><p>The true cost to our health and our environment has yet to be included in the equation. But once it is, maybe that is when the real shift will happen.</p>
- The Complex and Frustrating Reality of Recycling Plastic - EcoWatch ›
- The Recycling Dilemma: Good Plastic, Bad plastic? - EcoWatch ›
- The Myth About Recycling Plastic? It Works - EcoWatch ›
Plain Naturals is making waves in the CBD space with a new product line for retail customers looking for high potency CBD products at industry-low prices.
Is More CBD Really Better?<img lazy-loadable="true" src="https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNDU2ODQyNC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTYzMzYxMDMzN30.6B08i5QYW_Iq5bUf3qtm8oK8o6FKsRUZ74gdakgJ_TY/img.jpg?width=980" id="0ef5b" class="rm-shortcode" data-rm-shortcode-id="bac86abf3ce246742b18b0dc4052f4dd" data-rm-shortcode-name="rebelmouse-image" />
Plain Naturals offers a 5000mg CBD oil tincture in 30ml bottle for $99.99.<p>Consumers have gotten used to paying high prices for low amounts of cannabidiol. Plain Naturals is beginning to change that. There are myriad <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/%23:~:text=Chronic%2520use%2520and%2520high%2520doses,be%2520well%2520tolerated%2520by%2520humans.&text=Nonetheless%252C%2520some%2520side%2520effects%2520have,vitro%2520or%2520in%2520animal%2520studies." target="_blank" rel="noopener noreferrer nofollow">studies</a> showing that low doses of CBD (less than 50mg per day) are ineffective for many users. And many clinical <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/%23:~:text=Chronic%2520use%2520and%2520high%2520doses,be%2520well%2520tolerated%2520by%2520humans.&text=Nonetheless%252C%2520some%2520side%2520effects%2520have,vitro%2520or%2520in%2520animal%2520studies." target="_blank" rel="noopener noreferrer nofollow">studies</a> have shown effective dosages of 100 - 800mg per day to be effective for many conditions ranging from <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/%23:~:text=Chronic%2520use%2520and%2520high%2520doses,be%2520well%2520tolerated%2520by%2520humans.&text=Nonetheless%252C%2520some%2520side%2520effects%2520have,vitro%2520or%2520in%2520animal%2520studies." target="_blank" rel="noopener noreferrer nofollow">anxiety and depression to Parkinson's disease and cancer</a>. And several <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/%23:~:text=Chronic%2520use%2520and%2520high%2520doses,be%2520well%2520tolerated%2520by%2520humans.&text=Nonetheless%252C%2520some%2520side%2520effects%2520have,vitro%2520or%2520in%2520animal%2520studies." target="_blank" rel="noopener noreferrer nofollow">studies</a> published by the National Institutes of Health have shown up to 1500mg per day to be consistently "well-tolerated" by adults. </p><p>Now it is always recommended to begin with a lower dosage and increase until an effective dose has been reached. But the advantage of starting with a higher potency CBD oil is that it is much easier to use less to start with and increase over time than to buy very low dose CBD oil and ultimately end up buying more and more stronger products. To start at 50mg per dose of a 5000mg oil, you would simply use ⅓ dropper or about 10-12 drops.</p>
The Truth About CBD Product Potency<img lazy-loadable="true" src="https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNDU2ODMyNC9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTYyNDc2NTg1N30.OAm3iOTO_pKZLXi7KdJ7n0DGOFMdOmIYuG4ArGooFC4/img.jpg?width=980" id="d657c" class="rm-shortcode" data-rm-shortcode-id="ee016a81b29caa699b9185b64ce345d6" data-rm-shortcode-name="rebelmouse-image" />
CBD gummies from Plain Naturals are 100% vegan and sugar free.<p>Unlike most CBD brands which can be much smoke and mirrors when it comes to stating their product quality, potency and consistency, PlainNaturals.com has <a href="https://plainnaturals.com/product-information" target="_blank" rel="noopener noreferrer nofollow">lab tests</a> conducted by FDA/DEA approved laboratories and publishes their product lab test <a href="https://plainnaturals.com/product-information" target="_blank" rel="nofollow noreferrer noopener">reports</a> right on their website so customers know the quality of the product they are buying. </p><p>In a recent <a href="https://crnusa.org/sites/default/files/RAC%2520attachments/CBD/CBD%2520RTC%2520Final.pdf" target="_blank" rel="noopener noreferrer nofollow">report</a> published by the Food and Drug Administration, FDA tested 147 cbd oils and cbd products. They found that of the 102 products that indicated a specific amount of CBD, 18 products (18%) contained less than 80% of the amount of CBD indicated; 46 products (45%) contained within 20% of the amount of CBD indicated; 38 products (37%) contained more than 120% of the amount of CBD indicated and of those 147 products, the FDA also found nearly half contained levels of THC above the limit of 3.1 mg per serving (or .3%). </p><p>So there's a 70% chance that a CBD consumer is not getting what they pay for and a 50% chance that the product they are buying may not be legal.</p><p>When you buy CBD oil online from <a href="https://plainnaturals.com/" target="_blank" rel="nofollow noreferrer noopener">PlainNaturals.com</a>, you also get an unconditional money back guarantee and the manufacturer's warranty of the product quality and potency.</p>
CBD and Hemp Creams offer high-benefit, low-cost options to consumers.<p>Plain Naturals has taken the uncertainty out of the online CBD store process. By offering detailed laboratory reports on all their products and offering a money back guarantee, PlainNaturals.com online CBD store puts control back in the hands of the consumer when it comes to making their decision about where to buy CBD online.</p><p>In all 50 states and at the federal level it is 100% legal to <a href="https://plainnaturals.com/shop/ols/categories/cbd-oils" target="_blank" rel="nofollow noreferrer noopener">buy CBD oil online</a> from an online CBD store provided that the product meets the standards set forth in federal regulations, containing not more than 0.3% THC and manufactured from industrial hemp.</p><p><a href="https://plainnaturals.com/" target="_blank" rel="noopener noreferrer nofollow">PlainNaturals.com</a> offers CBD (Cannabidiol) products like <a href="https://plainnaturals.com/shop/ols/categories/cbd-oils" target="_blank" rel="noopener noreferrer nofollow">CBD Oils</a>, <a href="https://plainnaturals.com/shop/ols/categories/cbd-gummies--edibles" target="_blank" rel="noopener noreferrer nofollow">CBD gummies and edibles</a>, <a href="https://plainnaturals.com/shop/ols/categories/cbd-isolate-powder" target="_blank" rel="noopener noreferrer nofollow">CBD isolate powder</a>, wholesale CBD, <a href="https://plainnaturals.com/shop/ols/categories/cbd--hemp-creams--lotions" target="_blank" rel="noopener noreferrer nofollow">CBD and hemp cream</a> and <a href="https://plainnaturals.com/shop/ols/categories/essential-oils--aromatherapy" target="_blank" rel="noopener noreferrer nofollow">essential oils</a>. <a href="https://plainnaturals.com/" target="_blank" rel="noopener noreferrer nofollow">PlainNaturals.com</a> continues to be a top supplier of wholesale CBD products to retailers and has also opened a retailer online portal for stores and CBD dealers to buy CBD in bulk.</p><p>EcoWatch readers can take advantage of a special offer from <a href="https://plainnaturals.com/" target="_blank" rel="noopener noreferrer nofollow">PlainNaturals.com</a> and save an additional 25% off any purchase of $99 or more through 10/31/20 with coupon code <strong>ecowatch25</strong>.</p>
Towards the end of the final presidential debate of the 2020 election season, the moderator asked both candidates how they would address both the climate crisis and job growth, leading to a nearly 12-minute discussion where Donald Trump did not acknowledge that the climate is changing and Joe Biden called the climate crisis an existential threat.
- As Biden Embraces More Ambitious Climate Plan, Fossil Fuel Execs ... ›
- Climate Crisis Gets 10 Minutes at VP Debate - EcoWatch ›
- Climate Crisis Gets Just 10 Minutes at End of Presidential Debate ... ›
By Zheng Chen and Darren H. S. Tan
As concern mounts over the impacts of climate change, many experts are calling for greater use of electricity as a substitute for fossil fuels. Powered by advancements in battery technology, the number of plug-in hybrid and electric vehicles on U.S. roads is increasing. And utilities are generating a growing share of their power from renewable fuels, supported by large-scale battery storage systems.